News
-
-
PRESS RELEASE
PREATONI Group, an international group specializing in tourist resorts ownership and operations and real estate development, announces the Q3 revenue for its subsidiary Pro Kapital Grupp
PREATONI Group's subsidiary AS Pro Kapital Grupp reports Q3 revenue growth and progress updates on real estate projects in Baltic States. Financial results include significant revenue and profit increases -
-
-
PRESS RELEASE
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, the first and only multiple sclerosis biosimilar, offering cost-effective treatment. TYRUKO® approved for all indications of reference medicine Tysabri® -
-
-
-
-
PRESS RELEASE
Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
